DCT
1:22-cv-01040
Novo Nordisk Inc v. Mylan Pharma Inc
General
Filed
08/08/22
Cause of ActionPatent Infringement
SectorMech Eng, Manuf
Status
Closed (09/11/24)
Patent Owner
NPEÂ (L)
PACER
1:22-cv-01040
Nature of Suit835 ANDA
CourtD. Delaware
Judge | Period | PO Win Rate |
|---|---|---|
08/22/22 - 10/02/24 | 44% | |
03/25/22 - 08/22/22 | 58% | |
03/25/22 - 03/25/22 | 50% |
Plaintiff
Attorney
Name | Ratings |
|---|---|
L5 A | |
L5 A | |
L5 A | |
L1 E | |
L4 A | |
L4 A | |
L2 A | |
L2 B | |
L1 B | |
L1 B | |
L1 E | |
-- -- -- | |
-- -- -- | |
-- -- -- | |
-- -- -- | |
-- -- -- | |
L2 D | |
L2 C | |
L1 E |
No Attorneys
Defendant
Attorney
Name | Ratings |
|---|---|
L5 A | |
L4 A | |
L4 A | |
L4 E | |
L3 C | |
L2 B | |
L2 B | |
L1 A | |
L1 B | |
L1 D | |
L1 E | |
-- -- -- | |
L4 E | |
L5 E | |
L5 E | |
L4 E | |
L5 E | |
L3 D |
No Attorneys